No Data
Globus Medical(GMED.US) Director Sells US$4.09 Million in Common Stock
$Globus Medical(GMED.US)$ Director Lemaitre Dan sold 63,300 shares of common stock on May 10, 2024 at an average price of $64.6133 for a total value of $4.09 million.Source: Announcement What is state
Globus Medical Insider Sold Shares Worth $4,090,022, According to a Recent SEC Filing
Dan Lemaitre, Director, on May 10, 2024, sold 63,300 shares in Globus Medical (GMED) for $4,090,022. SEC Filing: https://www.sec.gov/Archives/edgar/data/1237831/000095017024059787/xslF345X03/ownership
There May Be Reason For Hope In Globus Medical's (NYSE:GMED) Disappointing Earnings
Globus Medical, Inc.'s (NYSE:GMED) recent soft profit numbers didn't appear to worry shareholders, as the stock price showed strength. However, we think the company is showing some signs that things
Morgan Stanley Raises Price Target on Globus Medical to $67 From $57, Keeps Equalweight Rating
Globus Medical (GMED) has an average investment rating of outperform among analysts polled by Capital IQ, with price targets ranging from $55 to $85. Price: 62.33, Change: -2.40, Percent Change: -3.70
Analysts Offer Insights on Healthcare Companies: Teva Pharmaceutical (TEVA), Globus Medical (GMED) and DENTSPLY SIRONA (XRAY)
Truist Financial Keeps Their Hold Rating on Globus Medical (GMED)